INTERMED: a measure of biopsychosocial case complexity: one year stability in Multiple Sclerosis patients

被引:24
|
作者
de Jonge, P [1 ]
Hoogervorst, ELJ
Huyse, FJ
Polman, CH
机构
[1] Univ Groningen, Dept Psychiat, Groningen, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands
关键词
biopsychosocial; case complexity; reliability; multiple sclerosis; INTERMED;
D O I
10.1016/j.genhosppsych.2003.09.001
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The 1-year temporal stability of the INTERMED in a sample of patients with relatively stable care needs, patients with established Multiple Sclerosis (MS) was analyzed. Seventy MS patients underwent an interview to assess the INTERMED by a trained nurse, and two examinations of disability, EDSS and GNDS by medical doctors. At the following appointment with the nurse, approximately 1 year later, a second INTERMED assessment was done. Spearman correlations and change scores between the INTERMED assessments were calculated. Correlations between the two assessments were considerable: 0.75 for the total score and 0.55-0.74 for the domain scores (all P < .05). Median change of all four INTERMED domain scores and total score were 0. Changes in INTERMED total scores tended to be associated with changes in EDSS scores over time (P = 0.09), but not with changes in GNDS scores (P = 0.67). Patients with INTERMED scores above 20 on at least one of the two assessments had longer disease duration (P < 0.01), were more frequently suffering from a chronic form of MS (P < 0.01), and had more disability on EDSS (P < 0.01) and GNDS (P < 0.01) assessments. In a sample of patients with an established diagnosis of MS, INTERMED scores remained fairly stable over the period of a year. Implementing the INTERMED in routine care of patients with chronic conditions may help the clinician to structure interdisciplinary care. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 50 条
  • [1] Operationalization of biopsychosocial case complexity in general health care:: the INTERMED project
    de Jonge, P
    Huyse, FJ
    Slaets, JPJ
    Söllner, W
    Stiefel, FC
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2005, 39 (09): : 795 - 799
  • [2] Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients
    Batista, Ana Rita
    Silva, Susana
    Lencastre, Leonor
    Guerra, Marina Prista
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
  • [3] The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment
    Hoogervorst, ELJ
    de Jonge, P
    Jelles, B
    Huyse, FJ
    Heeres, I
    van der Ploeg, HM
    Uitdehaag, BMJ
    Polman, CH
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01): : 20 - 24
  • [4] Biopsychosocial complexity in patients scheduled for elective TKA surgery: A feasibility pilot study with the INTERMED self-assessment questionnaire
    van der Linde, M. L.
    Baas, D. C.
    van der Goot, T. H.
    Vervest, A. M. J. S.
    Latour, C.
    [J]. INTERNATIONAL JOURNAL OF ORTHOPAEDIC AND TRAUMA NURSING, 2024, 53
  • [5] Autoimmune disorders in patients with multiple sclerosis: a one-year experience
    Palavra, F.
    Marado, D.
    Gens, H.
    Nunes, C. C.
    Goncalves, G.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S164 - S164
  • [6] Postural control in multiple sclerosis: Stability and complexity analyses
    van Emmerik, Richard E. A.
    Busa, Michael A.
    Hamill, Joseph
    [J]. JOURNAL OF SPORT & EXERCISE PSYCHOLOGY, 2011, 33 : S23 - S23
  • [7] INTERMED - An assessment and classification system for case complexity - Results in patients with low back pain
    Stiefel, FC
    de Jonge, P
    Huyse, FJ
    Slaets, JPJ
    Guex, P
    Lyons, JS
    Vannotti, M
    Fritsch, C
    Moeri, R
    Leyvraz, PF
    So, A
    Spagnoli, J
    [J]. SPINE, 1999, 24 (04) : 378 - 384
  • [8] Functional brain network stability in natalizumab treated multiple sclerosis patients: a one year follow-up study
    Meijer, K. A.
    Wiebenga, O.
    Eijlers, A. J.
    Steenwijk, M. D.
    Geurts, J. J.
    Schoonheim, M. M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 808 - 809
  • [9] What to expect one year after natalizumab discontinuation in multiple sclerosis patients
    Sangalli, F.
    Moiola, L.
    Ferre, L.
    Radaelli, M.
    Barcella, V.
    Martinelli, V.
    Comi, G.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 : S108 - S108
  • [10] One-year cognitive follow-up in patients with multiple sclerosis
    Lopez-Gongora, M.
    Garcia-Sanchez, C.
    Campolongo, A.
    Escartin, A.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S144 - S144